Correlation Between Teva Pharma and Creative Edge
Can any of the company-specific risk be diversified away by investing in both Teva Pharma and Creative Edge at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Teva Pharma and Creative Edge into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Teva Pharma Industries and Creative Edge Nutrit, you can compare the effects of market volatilities on Teva Pharma and Creative Edge and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Teva Pharma with a short position of Creative Edge. Check out your portfolio center. Please also check ongoing floating volatility patterns of Teva Pharma and Creative Edge.
Diversification Opportunities for Teva Pharma and Creative Edge
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Teva and Creative is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Teva Pharma Industries and Creative Edge Nutrit in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Creative Edge Nutrit and Teva Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Teva Pharma Industries are associated (or correlated) with Creative Edge. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Creative Edge Nutrit has no effect on the direction of Teva Pharma i.e., Teva Pharma and Creative Edge go up and down completely randomly.
Pair Corralation between Teva Pharma and Creative Edge
If you would invest 1,643 in Teva Pharma Industries on September 16, 2024 and sell it today you would earn a total of 7.00 from holding Teva Pharma Industries or generate 0.43% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 95.24% |
Values | Daily Returns |
Teva Pharma Industries vs. Creative Edge Nutrit
Performance |
Timeline |
Teva Pharma Industries |
Creative Edge Nutrit |
Teva Pharma and Creative Edge Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Teva Pharma and Creative Edge
The main advantage of trading using opposite Teva Pharma and Creative Edge positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Teva Pharma position performs unexpectedly, Creative Edge can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Creative Edge will offset losses from the drop in Creative Edge's long position.Teva Pharma vs. Haleon plc | Teva Pharma vs. Bausch Health Companies | Teva Pharma vs. Zoetis Inc | Teva Pharma vs. Takeda Pharmaceutical Co |
Creative Edge vs. Emergent Biosolutions | Creative Edge vs. Bausch Health Companies | Creative Edge vs. Neurocrine Biosciences | Creative Edge vs. Teva Pharma Industries |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |